Serotonin 1A Agonists and Cognition in Schizophrenia
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
Examines cognitive functioning in patients with schizophrenia or schizoaffective disorder who
have been treated with antipsychotic medications. Patients will be assigned to take active
medication (Buspar)or placebo along with their prescribed antipsychotic medication for six
weeks. Patients' memory and problem-solving ability will be tested before and after
medication.
Phase:
Phase 3
Details
Lead Sponsor:
Northwestern University Vanderbilt University Medical Center
Collaborator:
National Alliance for Research on Schizophrenia and Depression